Skip to main content

16/12/2025 | 07:00 CET | Group Announcements

Sonova strengthens digital health portfolio with SilentCloud™ acquisition, advancing integrated hearing care

Stäfa (Switzerland), December 16, 2025 – Sonova, a leading provider of innovative hearing solutions, today announced the acquisition of SilentCloud™, a digital tinnitus management app offering evidence-based therapies through intuitive, user-friendly digital tools. The transaction addresses the needs of more than 740 million people worldwide living with tinnitus, a condition often linked to hearing loss and causing ringing or buzzing in the ears that impacts sleep, concentration, and quality of life.1 This acquisition reinforces Sonova’s strategic commitment to deliver holistic, customer-centric hearing care – tackling the full scope of hearing health challenges.

By bringing SilentCloud’s™ development in-house, Sonova fully integrates digital tinnitus therapy into its hearing care ecosystem and plans to expand the solution to new markets. The company is also working with national healthcare authorities to explore prescription and reimbursement options, making advanced tinnitus management accessible to more people.

“Improving people’s lives has always been at the heart of our innovation”, says Oliver Lux, Group Vice President Audiological Care and designated Regional President EMEA & LATAM at Sonova. “SilentCloud’s strong engagement during the pilot phase showed real value for users and clear market potential. By internalizing the development, we can now fully integrate a digital tinnitus therapy into Sonova’s ecosystem, strengthening our position as a leader in holistic, customer-focused hearing care.”

SilentCloud™ was first introduced by Sonova in 2023 in partnership with Aureliym and quickly gained momentum in Belgium, Italy, Ireland, Luxembourg, Switzerland, and the United States. In the U.S., a dedicated version was developed with Phonak Government Services for the Department of Veterans Affairs to address the high incidence of tinnitus among veterans.

Nicholai Dessypris, President of Hearing Instruments North America and designated Regional President North America at Sonova, says: “Tinnitus affects nearly 3 million U.S. veterans, and many audiologists at the Department of Veterans Affairs (VA) already use SilentCloud to extend care beyond the clinic. By delivering structured education, sound therapy, and cognitive-behavioral tools directly to patients’ homes, SilentCloud helps improve hearing health outcomes. This acquisition strengthens our position as a trusted innovator in the U.S. market and reinforces our commitment to veterans’ care.”

The importance of tinnitus treatment

Tinnitus affects up to 15% of the global population, creating significant personal and societal impacts, including reduced productivity and increased healthcare costs.1,2 It can disrupt sleep, reduce concentration, impact emotional wellbeing, and lower overall quality of life.3 Early intervention through personalized therapies is shown to alleviate symptoms for many patients and improve quality of life and daily functioning.3 SilentCloud™ provides a self-paced program combining Cognitive Behavioral Therapy (CBT), multiple forms of sound therapy, and psycho-educational tools. The app empowers users to better understand and manage their tinnitus, while supporting physicians and hearing care professionals in patient and customer care.

 

References:

1 Jarach CM, Lugo A, Scala M, van den Brandt PA, Cederroth CR, Odone A, Garavello W, Schlee W, Langguth B, Gallus S. Global Prevalence and Incidence of Tinnitus: A Systematic Review and Meta-analysis. JAMA Neurol. 2022 Sep 1 ;79(9):888-900. doi: 10.1001/jamaneurol.2022.2189. Erratum in : JAMA Neurol. 2023 Feb 1 ;80(2) :216. doi: 10.1001/jamaneurol.2022.4248. PMID: 35939312; PMCID: PMC9361184.

2 Trochidis I, Lugo A, Borroni E, Cederroth CR, Cima R, Kikidis D, Langguth B, Schlee W, Gallus S. Systematic Review on Healthcare and Societal Costs of Tinnitus. Int J Environ Res Public Health. 2021 Jun 26;18(13):6881. doi: 10.3390/ijerph18136881. PMID: 34206904; PMCID: PMC8297244.

3 Cima, R. F., Mazurek, B., Haider, H., Kikidis, D., Lapira, A., Noreña, A., & Hoare, D. J. (2019). A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment. Hno, 67(1), 10-42.

– End –